PMC6193800_01
Normal looking bladder on videourodynamic study.
10-1055-s-0038-1672147-i180405cr-1.jpg
PMC6193800_01_10-1055-s-0038-1672147-i180405cr-1.jpg
FI180405cr-1
O. On vesicocystourethrogram (VCUG), there was no vesicoureteral reflux, a smooth bladder wall and closed bladder neck ( Fig. 1 ). 
Wounds after bilateral S3 neurostimulator implantation.
10-1055-s-0038-1672147-i180405cr-2.jpg
PMC6193800_01_10-1055-s-0038-1672147-i180405cr-2.jpg
FI180405cr-2
As the patient restored her voiding completely back to normal when switching on the neurostimulators and experienced no side effects, she could undergo the second phase 4 weeks later:permanent subcutaneous implantation of the neurostimulators ( Fig. 2 ).
Transcutaneous remote control of current intensity of the S3 neurostimulators.
10-1055-s-0038-1672147-i180405cr-3.jpg
PMC6193800_01_10-1055-s-0038-1672147-i180405cr-3.jpg
FI180405cr-3
 With a transcutaneous remote control, she was able to modify the intensity of stimulating current to avoid any discomfort ( Fig. 3 ).